Medical Oncology

, Volume 28, Issue 1, pp 105–111 | Cite as

Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells

Original paper


Cisplatin (DDP)-based adjuvant chemotherapy is widely used for the treatment of esophageal cancer. However, DDP resistance has become more common and thus new approaches are required to be explored. Cisplatin was used to induce autophagy in the human esophageal cancer cell line, EC9706 cells, and the effect of autophagy on the survival of EC9706 cells was investigated using an autophagy inhibitor 3-MA. Cell viability was measured by CCK8 assay. Apoptosis and cell cycle were detected by flow cytometry. Monodansylcadaverine (MDC) was used to detect autophagy. Western blotting assay was used to investigate the molecular changes that occurred in the course of treatment. DDP inhibited cell proliferation, induced cell death and cell cycle arrest at S phage. Moreover, autophagy was activated through class III PI3K pathway. The expression of autophagy-related Beclin1 and LC3-I was up-regulated and part of LC3-I was converted into LC3-II. However, after the combination treatment of 3-MA and DDP, the cell inhibitory rate increased; the apoptosis rate and the numbers of cells in S phase also increased. Furthermore, the accumulation of autophagic vacuoles was decreased; the expression of Beclin1 and LC3 was significantly down-regulated and the release of cytochrome c was decreased. DDP-induced apoptosis in EC9706 cells can be enhanced by the inhibitor of autophagy, 3-MA. Autophagy might play a role as a self-protective mechanism in DDP-treated esophageal cancer cells, and its inhibition could be a novel strategy for the adjuvant chemotherapy of esophageal cancer.


Autophagy Apoptosis Esophageal squamous cell carcinoma Cisplatin 


  1. 1.
    Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18–29.PubMedCrossRefGoogle Scholar
  2. 2.
    Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241–52.PubMedCrossRefGoogle Scholar
  3. 3.
    Sun Y, Peng ZL. Programmed cell death and cancer. Postgrad Med J. 2009;85:134–40.PubMedCrossRefGoogle Scholar
  4. 4.
    Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132:27–42.PubMedCrossRefGoogle Scholar
  5. 5.
    Kroemer G, et al. Classification of cell death: recommendations of the nomenclature committee on cell death. Cell Death Differ. 2005;12:1463–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Li J, et al. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol. 2009;16:761–71.PubMedCrossRefGoogle Scholar
  7. 7.
    Lomonaco SL, et al. The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. Int J Cancer. 2009;125:717–22.PubMedCrossRefGoogle Scholar
  8. 8.
    Chen Y, Lu Y, Lu C, Zhang L. Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression. Pathol Oncol Res. 2009. doi: 10.1007/s12253-008-9143-8.
  9. 9.
    Munafo DB, Colombo MI. A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. J Cell Sci. 2001;114:3619–29.PubMedGoogle Scholar
  10. 10.
    Biederbick A, Kern HF, Elsasser HP. Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol. 1995;66:3–14.PubMedGoogle Scholar
  11. 11.
    Goodsell DS. The molecular perspective: cytochrome c and apoptosis. Stem Cells. 2004;22:428–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Liang XH, et al. Induction of autophagy and inhibition of tumorgenesis by Beclin1. Nature. 1999;402:672–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Kabeya Y, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000;19:5720–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Galluzzi L, et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryote. Cell Death Differ. 2009;16:1093–107.PubMedCrossRefGoogle Scholar
  15. 15.
    Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science. 2004;306:990–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 2007;33:9–23.PubMedCrossRefGoogle Scholar
  17. 17.
    Lefranc F, Kiss R. Autophagy, the Trojan horse to combat glioblastomas. Neurosurg Focus. 2006;20:E7. doi:10.3171/foc.2006.20.4.4.PubMedCrossRefGoogle Scholar
  18. 18.
    Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22:7265–79.PubMedCrossRefGoogle Scholar
  19. 19.
    Kartalou M, Essigmann JM. Mechanisms of resistance to cisplatin. Mutat Res. 2001;478:23–43.PubMedGoogle Scholar
  20. 20.
    Seglen PO, Gordon PB. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci USA. 1982;79:1889–92.PubMedCrossRefGoogle Scholar
  21. 21.
    Lum JJ, et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell. 2005;120:237–48.PubMedCrossRefGoogle Scholar
  22. 22.
    Herman-Antosiewicz A, Johnson DE, Singh SV. Sulforaphane causes autophagy to inhibit release of cytochrome c and apoptosis in human prostate cancer cells. Cancer Res. 2006;66:5828–35.PubMedCrossRefGoogle Scholar
  23. 23.
    Nishikawa T, et al. Inhibition of autophagy potentiates sulforaphane—induced apoptosis in human colon cancer cells. Ann Surg Oncol. 2009 [Epub ahead of print]. doi: 10.1245/s10434-009-0696-x.
  24. 24.
    Degenhardt K, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell. 2006;10:51–64.PubMedCrossRefGoogle Scholar
  25. 25.
    Karantza-Wadsworth V, et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev. 2007;21:1621–35.PubMedCrossRefGoogle Scholar
  26. 26.
    Katayama M, Kawaguchi T, Berger MS, Pieper RO. DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ. 2007;14:548–58.PubMedCrossRefGoogle Scholar
  27. 27.
    Pan J, et al. Autophagy induced by farnesyltransferase inhibitors in cancer cells. Cancer Biol Ther. 2008;7:1679–84.PubMedCrossRefGoogle Scholar
  28. 28.
    Park MA, et al. Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. Cancer Biol Ther. 2008;7:1648–62.PubMedCrossRefGoogle Scholar
  29. 29.
    de Bruin EC, Medema JP. Apoptosis and non-apoptotic death in cancer development and treatment response. Cancer Treat Rev. 2008;34:737–49.PubMedCrossRefGoogle Scholar
  30. 30.
    Maiuri MC, et al. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ. 2009;16:87–93.PubMedCrossRefGoogle Scholar
  31. 31.
    Ding WX, et al. Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J Biol Chem. 2007;282:4702–10.PubMedCrossRefGoogle Scholar
  32. 32.
    Wu YC, et al. Inhibition of macroautophagy by bafilomycin A1 lowers proliferation and induces apoptosis in colon cancer cells. Biochem Biophys Res Commun. 2009;382:451–6.PubMedCrossRefGoogle Scholar
  33. 33.
    Gozuacik D, Kimch A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene. 2004;23:2891–906.PubMedCrossRefGoogle Scholar
  34. 34.
    Yang C, et al. Inhibition of autophagy induced by overexpression of mda-7/interleukin-24 strongly augments the antileukemia activity in vitro and in vivo. Cancer Gene Ther. 2009 [Epub ahead of print]. doi: 10.1038/cgt.2009.57.
  35. 35.
    Chen N, Karantza-Wadsworth V. Role and regulation of autophagy in cancer. Biochim Biophys Acta. 2009;1793:1516–23.PubMedCrossRefGoogle Scholar
  36. 36.
    Iwamaru A, et al. Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells. Oncogene. 2007;26:1840–51.PubMedCrossRefGoogle Scholar
  37. 37.
    Takeuchi H, et al. Synergistic augmentation of rapamycin-induced auto-phagy in malignant glioma cells by phosphatidylinositol 3-kinase protein kinase B inhibitors. Cancer Res. 2005;65:3336–46.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Donglei Liu
    • 1
  • Yang Yang
    • 1
  • Quan Liu
    • 1
  • Jianjun Wang
    • 1
  1. 1.Department of Thoracic Surgery, Union Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanPeople’s Republic of China

Personalised recommendations